Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mannkind Corp (NQ: MNKD )

4.110 +0.040 (+0.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,760,402
Open 4.110
Bid (Size) 4.100 (63)
Ask (Size) 4.250 (14)
Prev. Close 4.070
Today's Range 4.100 - 4.250
52wk Range 2.610 - 5.730
Shares Outstanding 263,923,726
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
MannKind Corporation to Participate in Oppenheimer 33rd Annual Healthcare Conference
From MannKind
Via Globe NewsWire
Looking Into MannKind's Return On Capital Employed
 
Via Benzinga

Performance

YTD
-21.11%
-21.11%
1 Month
-22.01%
-22.01%
3 Month
-19.57%
-19.57%
6 Month
+21.96%
+21.96%
1 Year
+18.79%
+18.79%

More News

Read More
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
Via Benzinga
Kratos Defense & Security, Zeta Global, Beacon Roofing Supply And Other Big Stocks Moving Higher On Friday
Via Benzinga
MannKind (MNKD) Q4 2022 Earnings Call Transcript
Via The Motley Fool
MannKind Earnings Preview
Via Benzinga
MannKind's Return On Capital Employed Overview
Via Benzinga
MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results
From MannKind
Via Globe NewsWire
MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference
From MannKind
Via Globe NewsWire
MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023
From MannKind
Via Globe NewsWire
MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript
Via The Motley Fool
Earnings Scheduled For February 23, 2023
Via Benzinga
Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference
From MannKind
Via Globe NewsWire
MannKind Corporation to Participate in the Lytham Partners Investor Select Conference
From MannKind
Via Globe NewsWire
MannKind’s Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease
From MannKind
Via Globe NewsWire
3 Biotech Stocks Under $15 Worth a Second Look in 2023
Via The Motley Fool
MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference
From MannKind
Via Globe NewsWire
MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting
From MannKind
Via Globe NewsWire
MannKind To Rally 57%? Here Are 5 Other Price Target Changes For Wednesday
Via Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
Via Benzinga
MannKind Corporation Reports 2022 Third Quarter Financial Results
From MannKind
Via Globe NewsWire
Earnings Preview: MannKind
Via Benzinga
MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022
From MannKind
Via Globe NewsWire
7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up
Via InvestorPlace
7 Penny Stocks That Actually Have a Buy Rating
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.